On the second day of the AACR meeting, Jonathan Grinstein, PhD, senior editor at GEN joined Julianna LeMieux, PhD, GEN’s deputy editor in chief, to chat about how they spent their day. Grinstein describes his excitement surrounding cancer vaccines while LeMieux shares some takeaways from the Expo Hall and spotlight theaters including Revvity and genomics companies such as Canopy Biosciences, Akoya Biosciences, Alamar Biosciences, Singular Genomics, and SomaLogic.

MultimediaNewsVideosCancer vaccineLiver cancerProtein biomarkerProteomicsAkoya BiosciencesAlamar BiosciencesCanopy BiosciencesRevvitySingular Genomics SysSomaLogic
Previous articleSeaport Therapeutics Launches with $100M Series A
Next articleCRISPR Concerns Won’t Spoil Its Promise—If We Use the Right Tools